Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study.

Objective: The SABINA (SABA use IN Asthma) program was initiated to describe short-acting β2-agonists (SABA) prescription patterns and assess the impact of its over-prescription on exacerbation risk and asthma control. We evaluated SABA prescription patterns in patients with asthma in the Indian cohort of SABINA III.

Methods: This multi-centre, observational, cross-sectional study included retrospective and real-time electronic data collection.